IL6 and Alzheimer disease: We found that PBLs isolated from AD patients exhibited lower baseline peripheral immune cell activity (unstimulated), as evidenced by the significantly reduced release of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, but not IFN-γ and IL-15, compared to cognitively healthy controls (HCs).